We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Showcases New Launches at MEDICA 2019

By LabMedica International staff writers
Posted on 20 Nov 2019
Print article
Image: Electrolyte Analyser EC90 (Photo courtesy of Erba Mannheim)
Image: Electrolyte Analyser EC90 (Photo courtesy of Erba Mannheim)
Erba Mannheim (London, UK) showcased some exciting new launches and provided a preview of NEXUS, its future generation of hematology, chemistry and immunoassay systems, at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. MEDICA is the world's largest annual medical technology trade fair and provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

Erba Mannheim is an emerging player in the global IVD market and offers innovative solutions for lab diagnostics. At MEDICA 2019, the company showcased some of its new launches, including its new EC90 electrolyte analyzer with maintenance-free electrodes in an all-in-one sensor cartridge that is aimed at labs of all sizes. The EC 90 directly measures Na+, Cl-, K+ and Ca2+ from whole blood, plasma, serum and pre-diluted urine using a sensor incorporating thick film technology. The ‘plug and play’ sensor cartridge is integrated into a new reagent pack capable of performing up to 3,000 samples, with a market leading on-board lifetime of three months. No maintenance or cleaning of the pack is required, and waste is self-contained. The EC 90 can analyze samples in 35 seconds, with a typical throughput of 90 samples/hour, and has 35µL and 70µL sample volume measuring modes. Results can be given with a resolution of 0.1mmol/L for Na+ and Cl-, 0.01mmol/L for K+ and Ca2+, and are reproducible with CV< 1%. Small and lightweight (337 x 273 x 422mm, <8kg), the EC 90 features an 8.5-inch color touchscreen display, LIS connectivity, automatic calibration, two USB ports, on-board 24 column thermal printer and a serial port.

Erba Mannheim also showcased the ELAN 30s, a new fully automated compact benchtop ELISA microstrip processor with easy-to-use software, including QC reports and the ability to perform six different tests simultaneously. ELAN 30s eliminates the need for a ELISA reader and washer, making it the ultimate automated solution for labs with small, medium and varied ELISA workloads.

Also on display at this year’s MEDICA was Erba Mannheim’s XL 200 fully automated random access clinical chemistry analyzer with a throughput of 200 tests/hour (photometric test) and 400 tests/hour with ISE (Na/K/Cl/Li). The XL 200 offers 30 position reagent tray with on-board cooling, convenient software and an extensive quality control menu.

At MEDICA 2019, Erba Mannheim provided a preview of its new NEXUS advanced automation range. NEXUS will provide labs with a modular solution designed to deliver mid-scale, advanced-automation across immunology, clinical chemistry and hematology, using a powerful array of technology such as advanced imaging, artificial intelligence, thick film ISE and high sensitivity magnetic beads for CLIA analysis.

Related Links:
Erba Mannheim

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.